161 related articles for article (PubMed ID: 36562811)
1. Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds.
Wan S; Cao J; Chen S; Yang J; Wang H; Wang C; Li K; Yang L
J Cancer Res Clin Oncol; 2023 Jan; 149(1):281-296. PubMed ID: 36562811
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.
Xu W; Anwaier A; Ma C; Liu W; Tian X; Palihati M; Hu X; Qu Y; Zhang H; Ye D
Ann Med; 2021 Dec; 53(1):596-610. PubMed ID: 33830879
[TBL] [Abstract][Full Text] [Related]
3. Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa.
Davalieva K; Kiprijanovska S; Ivanovski O; Trifunovski A; Saidi S; Dimovski A; Popov Z
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834386
[TBL] [Abstract][Full Text] [Related]
4. Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
Xu Y; Sun X; Liu G; Li H; Yu M; Zhu Y
Front Immunol; 2023; 14():1301157. PubMed ID: 38299148
[TBL] [Abstract][Full Text] [Related]
5. Biochemical network analysis of protein-protein interactions to follow-up T1 bladder cancer patients.
Carvalho LB; Martínez JLC; Lodeiro C; Bento R; Dhir R; Morrissey JJ; Pinheiro LC; Medeiros M; Santos HM
J Proteomics; 2023 Apr; 278():104865. PubMed ID: 36870676
[TBL] [Abstract][Full Text] [Related]
6. A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer.
Wang W; Zhang X; Jiang S; Xu P; Chen K; Li K; Wang F; Le X; Zhang K
Front Immunol; 2023; 14():1187286. PubMed ID: 37691944
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
[TBL] [Abstract][Full Text] [Related]
8. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.
Huttanus HM; Vu T; Guruli G; Tracey A; Carswell W; Said N; Du P; Parkinson BG; Orlando G; Robertson JL; Senger RS
PLoS One; 2020; 15(8):e0237070. PubMed ID: 32822394
[TBL] [Abstract][Full Text] [Related]
9. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
Kural S; Jain G; Agarwal S; Das P; Kumar L
Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Zhang C; Shen K; Zheng Y; Qi F; Luo J
Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach.
Soares NC; Ali A; Srinivasulu V; Sharaf BM; Giddey AD; Okendo J; Al-Hroub HM; Semreen MH; Hamad M; Al-Tel TH
J Proteomics; 2022 Aug; 265():104660. PubMed ID: 35728772
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
Cai H; Chen H; Huang Q; Zhu JM; Ke ZB; Lin YZ; Zheng QS; Wei Y; Xu N; Xue XY
Pathol Oncol Res; 2021; 27():1609941. PubMed ID: 34776794
[No Abstract] [Full Text] [Related]
14. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
[TBL] [Abstract][Full Text] [Related]
15. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
Chen X; Zhang J; Ruan W; Huang M; Wang C; Wang H; Jiang Z; Wang S; Liu Z; Liu C; Tan W; Yang J; Chen J; Chen Z; Li X; Zhang X; Xu P; Chen L; Xie R; Zhou Q; Xu S; Irwin DL; Fan JB; Huang J; Lin T
J Clin Invest; 2020 Dec; 130(12):6278-6289. PubMed ID: 32817589
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples.
Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W
Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388
[TBL] [Abstract][Full Text] [Related]
17. Identifying a prognostic model and screening of potential natural compounds for acute myeloid leukemia.
Sun XH; Wan S; Chai YH; Bai XT; Li HX; Xi YM
Transl Cancer Res; 2023 Jun; 12(6):1535-1551. PubMed ID: 37434693
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
[TBL] [Abstract][Full Text] [Related]
19. High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer.
Zhang X; Liu J; Yang X; Jiao W; Shen C; Zhao X; Wang Y
Cell Cycle; 2023 Mar; 22(5):610-618. PubMed ID: 36474424
[TBL] [Abstract][Full Text] [Related]
20. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
